dc.contributorHosp Renascentista
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorUniversidade de São Paulo (USP)
dc.contributorHosp AC Camargo Fund Antonio Prudente
dc.creatorBeraldo, Daniel Oliveira [UNIFESP]
dc.creatorMelo, Joanderson Fernandes
dc.creatorBonfim, Alexandre Vidal [UNIFESP]
dc.creatorTeixeira, Andrei Alkmim [UNIFESP]
dc.creatorTeixeira, Ricardo Alkmim
dc.creatorDuarte, Andre Loyola
dc.date.accessioned2016-01-24T14:34:51Z
dc.date.accessioned2022-10-07T21:17:27Z
dc.date.available2016-01-24T14:34:51Z
dc.date.available2022-10-07T21:17:27Z
dc.date.created2016-01-24T14:34:51Z
dc.date.issued2013-12-14
dc.identifierWorld Journal of Gastroenterology. Wanchai: Baishideng Publ Grp Co Ltd, v. 19, n. 46, p. 8789-8792, 2013.
dc.identifier1007-9327
dc.identifierhttp://repositorio.unifesp.br/handle/11600/37081
dc.identifier10.3748/wjg.v19.i46.8789
dc.identifierWOS:000329129200039
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4028202
dc.description.abstractAmoxicillin/clavulanate is a synthetic penicillin that is currently commonly used, especially for the treatment of respiratory and cutaneous infections. in general, it is a well-tolerated oral antibiotic. However, amoxicillin/clavulanate can cause adverse effects, mainly cutaneous, gastrointestinal, hepatic and hematologic, in some cases. Presented here is a case report of a 63-year-old male patient who developed cholestatic hepatitis after recent use of amoxicillin/clavulanate. After 6 wk of prolonged use of the drug, he began to show signs of cholestatic icterus and developed severe hyperbilirubinemia (total bilirubin > 300 mg/L). Diagnostic investigation was conducted by ultrasonography of the upper abdomen, serum tests for infection history, laboratory screening of autoimmune diseases, nuclear magnetic resonance (NMR) of the abdomen with bile duct-NMR and transcutaneous liver biopsy guided by ultrasound. the duration of disease was approximately 4 mo, with complete resolution of symptoms and laboratory changes at the end of that time period. Specific treatment was not instituted, only a combination of anti-emetic (metoclopramide) and cholestyramine for pruritus. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
dc.languageeng
dc.publisherBaishideng Publ Grp Co Ltd
dc.relationWorld Journal of Gastroenterology
dc.rightsAcesso aberto
dc.subjectHepatology
dc.subjectHepatitis
dc.subjectAmoxicillin/Clavulanate
dc.subjectDrug reactions
dc.subjectHyperbilirubinemia
dc.titleAcute cholestatic hepatitis caused by amoxicillin/clavulanate
dc.typeArtigo


Este ítem pertenece a la siguiente institución